Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 39Gynecologic 12CNS 5Breast 4Other neoplasm 3Lymphoid 3Gastrointestinal 3Other hematologic neoplasm 2Genitourinary 2Thoracic 1Sarcoma 1Head & Neck 1

Conditions

Stomach Neoplasms 1Squamous Intraepithelial Lesions 1Papillomavirus Infections 1HIV Infections 1Colorectal Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Imiquimod × Gastrointestinal × Clear all
NCT02135419 2024-07-26

ANCHOR

AIDS Malignancy Consortium

Phase 3 Completed
4,446 enrolled 13 charts
GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT02276300 2019-11-20

HER2

Technical University of Munich

Phase 1 Completed
2 enrolled
BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT00785122 2013-05-16

IMA910-101

Immatics Biotechnologies GmbH

Phase 1/2 Completed
92 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡